Korro Bio (KRRO) Competitors $14.81 +0.01 (+0.07%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$15.15 +0.34 (+2.30%) As of 05/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. BCYC, ANAB, COGT, VECT, SION, KROS, IMTX, TYRA, VALN, and MRVIShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Bicycle Therapeutics (BCYC), AnaptysBio (ANAB), Cogent Biosciences (COGT), VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Tyra Biosciences (TYRA), Valneva (VALN), and Maravai LifeSciences (MRVI). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Bicycle Therapeutics AnaptysBio Cogent Biosciences VectivBio Sionna Therapeutics Keros Therapeutics Immatics Tyra Biosciences Valneva Maravai LifeSciences Bicycle Therapeutics (NASDAQ:BCYC) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, community ranking, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Which has more risk and volatility, BCYC or KRRO? Bicycle Therapeutics has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.66, indicating that its stock price is 166% more volatile than the S&P 500. Do institutionals and insiders hold more shares of BCYC or KRRO? 86.2% of Bicycle Therapeutics shares are held by institutional investors. Comparatively, 13.2% of Korro Bio shares are held by institutional investors. 22.9% of Bicycle Therapeutics shares are held by company insiders. Comparatively, 4.6% of Korro Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in BCYC or KRRO? Bicycle Therapeutics received 114 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 70.53% of users gave Bicycle Therapeutics an outperform vote. CompanyUnderperformOutperformBicycle TherapeuticsOutperform Votes14670.53% Underperform Votes6129.47% Korro BioOutperform Votes32100.00% Underperform VotesNo Votes Which has better earnings and valuation, BCYC or KRRO? Korro Bio has lower revenue, but higher earnings than Bicycle Therapeutics. Bicycle Therapeutics is trading at a lower price-to-earnings ratio than Korro Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBicycle Therapeutics$25.72M21.81-$180.66M-$3.14-2.58Korro Bio$4.82M28.85-$81.17M-$9.44-1.57 Do analysts prefer BCYC or KRRO? Bicycle Therapeutics currently has a consensus target price of $25.00, suggesting a potential upside of 208.64%. Korro Bio has a consensus target price of $102.43, suggesting a potential upside of 591.62%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than Bicycle Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bicycle Therapeutics 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Korro Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29 Is BCYC or KRRO more profitable? Korro Bio has a net margin of 0.00% compared to Bicycle Therapeutics' net margin of -450.64%. Bicycle Therapeutics' return on equity of -27.35% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Bicycle Therapeutics-450.64% -27.35% -20.81% Korro Bio N/A -50.25%-38.48% Does the media favor BCYC or KRRO? In the previous week, Korro Bio had 1 more articles in the media than Bicycle Therapeutics. MarketBeat recorded 7 mentions for Korro Bio and 6 mentions for Bicycle Therapeutics. Bicycle Therapeutics' average media sentiment score of 1.18 beat Korro Bio's score of 0.59 indicating that Bicycle Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bicycle Therapeutics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Korro Bio 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryKorro Bio beats Bicycle Therapeutics on 10 of the 19 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$139.08M$6.47B$5.33B$8.39BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-1.579.0626.7119.71Price / Sales28.85251.50386.46120.65Price / CashN/A65.8538.2534.62Price / Book0.706.456.774.50Net Income-$81.17M$143.98M$3.23B$248.22M7 Day Performance-1.99%0.38%0.48%-0.78%1 Month Performance-17.54%2.14%9.10%11.53%1 Year Performance-69.20%-0.33%18.56%8.99% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.0073 of 5 stars$14.81+0.1%$102.43+591.6%-70.5%$139.08M$4.82M-1.5770Analyst RevisionGap DownBCYCBicycle Therapeutics3.9262 of 5 stars$8.60+3.1%$25.00+190.7%-62.2%$595.14M$25.72M-2.61240Gap UpANABAnaptysBio3.3389 of 5 stars$20.03+2.2%$35.88+79.1%-17.2%$588.48M$111.87M-3.29100Positive NewsCOGTCogent Biosciences2.3545 of 5 stars$5.13+6.7%$14.29+178.5%-38.4%$584.08MN/A-2.0780News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGap DownVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeSIONSionna TherapeuticsN/A$12.90+4.7%$38.50+198.4%N/A$569.20MN/A0.0035News CoverageAnalyst DowngradeGap DownKROSKeros Therapeutics3.2498 of 5 stars$13.74+0.7%$37.00+169.3%-72.3%$558.05M$214.71M-2.64100IMTXImmatics2.8104 of 5 stars$4.56+7.5%$16.67+265.5%-49.7%$554.27M$155.84M-6.91260News CoveragePositive NewsAnalyst DowngradeGap UpTYRATyra Biosciences1.6664 of 5 stars$10.26+1.7%$30.83+200.5%-45.8%$544.70MN/A-6.3720News CoveragePositive NewsAnalyst ForecastAnalyst RevisionVALNValneva2.1097 of 5 stars$6.45-0.3%$15.50+140.3%-27.5%$539.45M$169.58M-49.62700MRVIMaravai LifeSciences4.0599 of 5 stars$2.12+7.1%$6.34+199.2%-79.2%$539.19M$259.19M-1.29610Gap Up Related Companies and Tools Related Companies Bicycle Therapeutics Alternatives AnaptysBio Alternatives Cogent Biosciences Alternatives VectivBio Alternatives Sionna Therapeutics Alternatives Keros Therapeutics Alternatives Immatics Alternatives Tyra Biosciences Alternatives Valneva Alternatives Maravai LifeSciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRRO Stock Free KRRO Stock Alerts